GlassScriptPhysician profile
Lauren Moore
NPI 1578840922
$2,302.44
in general payments reported to CMS, 2019-2025
25 companies · $299 in 2025
The $299 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $231 · 2022: $731 · 2023: $666 · 2024: $375 · 2025: $299.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,340.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,340.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $480.03 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $260.82 | 2021-2023 | Trulance, Xifaxan |
| Takeda Pharmaceuticals U.S.A., INC. | $183.42 | 2021-2023 | Entyvio, Gattex |
| Janssen Biotech, INC. | $166.99 | 2022-2025 | Tremfya |
| Smith+Nephew, INC. | $144.39 | 2025 | Grafix Pl, Oasis, Oasis Micro |
| Haemonetics Corporation | $131.62 | 2023 | Teg6s Hemostasis System |
| Phathom Pharmaceuticals, INC. | $124.74 | 2024 | Voquezna |
| E.R. Squibb & Sons, L.L.C. | $121.95 | 2024 | Zeposia |
| Celgene Corporation | $108.47 | 2021-2023 | Zeposia |
| Merck Sharp & Dohme LLC | $73.66 | 2021-2023 | Dificid |
| Genzyme Corporation | $71.51 | 2022-2023 | |
| Qol Medical, LLC | $70.14 | 2022-2023 | Sucraid |
| Gilead Sciences, INC. | $69.42 | 2021-2023 | |
| Ironwood Pharmaceuticals, INC | $61.91 | 2022-2023 | Linzess |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.90 | 2025 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $26.68 | 2025 | Nemluvio |
| Nestle Healthcare Nutrition INC. | $26.46 | 2021 | |
| Ethicon US, LLC | $25.80 | 2021 | |
| Pharmacosmos Therapeutics INC. | $24.66 | 2022 | |
| Atricure, INC. | $23.51 | 2024 | |
| Intercept Pharmaceuticals, INC. | $19.03 | 2022 | |
| Pfizer INC. | $17.59 | 2022 | |
| W. L. Gore & Associates, INC. | $15.79 | 2022 | |
| Evoke Pharma, INC. | $14.01 | 2023 | Gimoti |
| Alexion Pharmaceuticals, INC. | $12.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.